CVS Health announced on November 4, 2026, that it intends to separate into two independent, publicly traded companies, dividing its retail pharmacy operations from its health insurance, pharmacy services and healthcare delivery businesses. The proposed CVS Health corporate separation follows a strategic review by the company’s board of directors, with completion targeted for the first half of 2028.
Key Takeaways
- CVS Health plans to separate into two independent, publicly traded companies
- The healthcare solutions company will include Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health
- CVS Pharmacy will operate approximately 9,000 retail pharmacies, mail pharmacy services, MinuteClinic facilities and Health100 technology services
- David Joyner is designated to lead the healthcare solutions company, while Prem Shah will lead CVS Pharmacy
- The separation is expected to be completed in the first half of 2028, subject to required approvals and other conditions
CVS Health Corporate Separation Would Create Two Independent Companies
The proposed CVS Health corporate separation would establish two publicly traded businesses with distinct operating responsibilities, leadership teams and capital structures.
The first company would focus on healthcare benefits, pharmacy services and care delivery. It would retain the CVS Health name on an interim basis and include the company’s insurance, pharmacy benefit management, specialty pharmacy and healthcare delivery operations.
The second company, CVS Pharmacy, would concentrate on retail pharmacy and community healthcare services. Its operations would include CVS retail locations, mail pharmacy services, MinuteClinic facilities and the Health100 technology services business.
CVS Health said the separation is intended to provide each organization with a more focused strategy and greater flexibility in allocating capital. The businesses would be able to make operating and investment decisions according to their respective priorities.
The announcement does not represent a completed separation. CVS Health will continue operating as one company until the transaction is finalized.
During the transition, CVS Health has stated that customers, patients and healthcare clients will continue receiving their existing medicines, care, benefits and services without interruption.
Healthcare Benefits and Services Businesses Will Remain Together
The proposed healthcare solutions company would combine five major businesses: Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health.
Aetna provides health insurance products and related services. CVS Caremark operates in pharmacy benefit management, while CVS Specialty focuses on specialty pharmacy services and medications.
Pharmacy benefit managers perform functions such as negotiating drug prices, processing prescription claims and managing pharmacy networks. These responsibilities are part of the wider discussion surrounding pharmacy benefit management transparency, including how employers and health plans evaluate prescription costs and benefits administration.
Oak Street Health and Signify Health would also remain within the healthcare solutions organization. Their operations include primary care, value-based care and in-home healthcare services.
Keeping these businesses together would preserve the existing relationship between CVS Health’s insurance, pharmacy benefit management and healthcare delivery operations. The planned separation would distinguish those activities from the company’s retail pharmacy business rather than separate Aetna from CVS Caremark.
CVS Health expects the healthcare solutions company to establish its own leadership structure and financial priorities. The organization would continue serving health plan members, clients and patients through its combined businesses.
Additional leadership appointments and details about the future company’s permanent name have not yet been announced.
CVS Pharmacy Will Retain Retail Locations and Community Healthcare Services
The second company would operate as CVS Pharmacy, bringing together the retail pharmacy network and related community healthcare operations.
Its business would include approximately 9,000 CVS pharmacy locations across the United States, alongside mail pharmacy operations and MinuteClinic facilities, including virtual care services.
CVS Pharmacy would also include Health100, the company’s technology services business. CVS Health has indicated that both future organizations intend to continue developing technology solutions associated with Health100.
The proposed retail company would provide pharmacy and community healthcare services through a network that currently includes nearly 30,000 pharmacists.
Beyond physical pharmacy locations, mail-order services would remain an important part of the planned business. Other models, including direct-to-patient prescription platforms, combine electronic prescribing, online consultations and medication shipment to coordinate prescription fulfillment.
CVS Health has also identified partnerships as an area of focus for the independent pharmacy company. These could include relationships with health insurers, pharmacy benefit managers and pharmaceutical manufacturers.
The separate corporate structure would allow CVS Pharmacy to establish its own operating and investment priorities. However, the company has not announced specific changes to its retail services or pharmacy network resulting from the separation.
Until the transaction is completed, CVS Pharmacy will remain part of the existing CVS Health organization.
David Joyner and Prem Shah Designated to Lead the Two Companies
CVS Health has announced its intended leadership structure for the two businesses following the separation.
David Joyner, currently chairman and CEO of CVS Health, is designated to become chairman and CEO of the healthcare solutions company.
Under the proposed arrangement, Joyner would oversee Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health.
Prem Shah, currently group president of CVS Health, is designated to become CEO of CVS Pharmacy. His responsibilities would center on the company’s retail pharmacy, mail pharmacy, community healthcare and related technology services operations.
The appointments would establish separate executive leadership for the two organizations. Each company is also expected to have its own board of directors and management structure.
CVS Health has not yet announced all executive appointments or board members for the future companies. Additional details are expected as the restructuring process advances.
Until the separation is completed, both executives will continue serving within the existing CVS Health corporate organization.
Separation Timeline Targets the First Half of 2028
CVS Health expects to complete the proposed separation during the first half of 2028.
The transaction remains subject to several conditions, including final approval from the CVS Health board of directors and the effectiveness of a Form 10 registration statement filed with the U.S. Securities and Exchange Commission.
The company must also receive customary confirmation concerning the intended tax treatment of the transaction.
CVS Health plans to structure the separation so that it is tax-free to the company and its shareholders for U.S. federal income tax purposes.
Under the proposed arrangement, existing CVS Health shareholders would own shares in both companies following completion.
The company also expects both organizations to have investment-grade credit ratings and sufficient financial flexibility to pursue their respective strategic priorities. These are expectations rather than confirmed financial outcomes.
The first-half 2028 timeline remains an estimate. The transaction could be delayed or changed if required conditions are not satisfied.
CVS Health has stated that it will provide further information as the separation process progresses. Until then, the existing corporate organization will continue operating its healthcare and retail pharmacy businesses.
Frequently Asked Questions
Why Is CVS Health Separating Its Pharmacy and Healthcare Businesses?
CVS Health said the proposed separation would allow its retail pharmacy and healthcare solutions businesses to operate with more focused strategies, dedicated leadership teams and independent capital structures. The decision followed a strategic review by the company’s board of directors.
Which Businesses Will Remain With CVS Health?
The healthcare solutions company will include Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health. It will use the CVS Health name on an interim basis.
What Will Be Included in the New CVS Pharmacy Company?
CVS Pharmacy will include approximately 9,000 retail pharmacy locations, mail pharmacy operations, MinuteClinic facilities, virtual care services and the Health100 technology services business.
Who Will Lead the Two Companies?
David Joyner is designated to become chairman and CEO of the healthcare solutions company. Prem Shah is expected to become CEO of CVS Pharmacy when the separation is completed.
Will CVS Health Shareholders Own Shares in Both Companies?
CVS Health expects existing shareholders to receive ownership interests in both companies after completion. The proposed transaction is intended to be tax-free for U.S. federal income tax purposes, subject to the required conditions.
When Will the CVS Health Corporate Separation Be Completed?
CVS Health is targeting the first half of 2028. Completion remains subject to final board approval, SEC filing requirements and confirmation of the intended tax treatment. The company has not announced a definitive completion date.
